This document is a financial statement detailing stock holdings as of April 2, 2014. It includes information on various biotech companies, their trade dates, quantities, current prices, unit costs, market values, total costs, and unrealized gains or losses.
documents/vol00010-efta01461523-pdf.pdf
{"document_date":"2014-04-02","document_type":"tabular","document_subtype":"financial statement","key_organizations":["Sangamo Biosciences","Biogen","Foundation Medicine","Gilead Sciences Inc","Ariad Pharmaceuticals"],"reference_numbers":["DB-SDNY-0123633","SDNY_GM_00269817","EFTA01461523"]}